Eligible Companies for Exchange

Nalu Medical develops neuro-stimulation devices aimed at alleviating chronic pain. The company's innovative battery-free, micro-implantable pulse generators focus on neuromodulation, offering diverse therapy options for spinal cord and peripheral nerve stimulation. This technology enables patients with clinical conditions to access appropriate treatments and effectively manage chronic pain.

Neuron23 develops an AI-driven drug discovery model focused on genetically defined neurological and immunological diseases. Using cutting-edge human genetics and their advanced AI-based drug discovery and biomarker platforms, Neuron23 aims to create therapeutics for severe diseases. This approach provides patients with genetic disorders access to improved medications.

NextPoint specializes in developing medications aimed at enhancing the effectiveness of immunotherapies for cancer patients. The company is focused on creating a comprehensive and strategic pipeline of pioneering immunotherapies, leveraging a novel and validated checkpoint axis. This approach enables healthcare professionals to broaden the scope and potential of immunotherapy treatments.

OrsoBio is a clinical-stage biopharmaceutical company focused on creating treatments for organ dysfunction. The firm is dedicated to developing therapies for obesity and related disorders, such as type 2 diabetes, MASH, and severe dyslipidemia. OrsoBio aims to enhance patients' energy metabolism, offering them improved health outcomes.

Ossium Health develops stem cell-based therapies aimed at enhancing human health, vitality, and longevity through bioengineering. These therapies target the cure of leukemia and other blood disorders, enhance organ transplantation outcomes, treat radiation poisoning, and facilitate tissue repair. By doing so, Ossium Health empowers healthcare professionals to significantly boost the well-being, vitality, and lifespan of individuals.

Ostro operates a patient engagement and telemedicine platform aimed at optimizing the patient journey, covering aspects from consumer interaction to provider education. Ostro's platform facilitates virtual consultations, manages shipping and logistics, ensures regulatory compliance, and integrates payment and financial services. This allows patients to access healthcare products and services through an online interface.

Overjet has developed an AI-driven dental platform aimed at enhancing patient care for dental payers and providers. The company's advanced artificial intelligence technology assists dental organizations in offering superior care to patients. This innovation enables dentists to accurately detect pathologies and confidently educate their patients, ensuring a higher quality of care.

Pager is a virtual care platform designed to provide improved tools and access to advocacy-based healthcare and support services. Its platform unites clinical and service teams, tools, services, and data into a single collaborative interface. Featuring a simple and intuitive messaging system, it includes triage nurses to direct members to the most convenient and cost-effective care options. It also connects users with providers through video consultations or scheduled visits with primary care doctors and specialists. This enables the healthcare industry to interact easily with their care teams and receive proper guidance.

Paradigm operates a health technology platform designed to support the clinical research ecosystem. The platform's purpose is to enhance the efficiency of clinical trials by connecting biopharmaceutical trial sponsors with healthcare providers and streamlining the process for patients. Paradigm aims to improve the healthcare sector by increasing trial efficiency, lowering participation barriers for healthcare providers, and accelerating the delivery of potentially life-saving treatments to patients.

Paradromics develops data-rate brain-computer interface technology aimed at enhancing data transmission rates between the human brain and machines. This technology provides high-volume, bidirectional data streaming between brains and computers, allowing patients with neurological disorders to overcome deficits in biological connectivity.

Pathalys Pharma develops advanced therapeutics aimed at addressing the unmet needs of managing late-stage chronic kidney diseases. The company has created upacicalcet, a novel calcimimetic designed to enhance the treatment of secondary hyperparathyroidism (SHPT) in hemodialysis patients. It works by mimicking calcium's effects on tissues through activating the calcium-sensing receptor found in various human organs. This innovation allows healthcare providers to better treat patients with end-stage critical kidney disease.

Pelago operates a behavioral therapy platform designed to empower individuals in overcoming addictions. The platform utilizes cognitive behavioral therapy to address the psychological aspects of addiction, helping users identify their triggers. Through animated videos, interactive exercises, and audio sessions, Pelago provides support to users, enabling them to tackle their addictions at their own pace. The platform offers a personalized coach, assisting users in their journey to recovery.

Pomelo Care is an online platform offering personalized, high-quality, and accessible maternity care for pregnant individuals and newborns. The company's service delivers customized, evidence-based prenatal and neonatal care through detailed care plans and engaging resources. This approach helps users address clinical, behavioral, and social needs, ultimately improving outcomes for both mothers and their babies.

Rad AI is the developer of a generative artificial intelligence solution platform designed to streamline healthcare workflows, save time for providers, and reduce burnout. The company's platform enhances workflow efficiency by integrating seamlessly with existing processes, automating repetitive and time-consuming tasks, and boosting overall productivity. This enables radiologists to improve their workflows, maximizing both efficiency and accuracy while decreasing patient turnaround time.

ReCode Therapeutics, a developer of targeted delivery technology, is designed to cater to patients suffering from rare diseases. The company's platform leverages lipid nanoparticles to deliver genetic therapies accurately to specific organs and tissues. This could potentially address the shortcomings of existing gene therapy methods and offer new hope for patients with unmet medical needs. Thus, providing healthcare firms that handle life-limiting respiratory diseases with access to effective treatments.

Regard is the developer of a healthcare platform aimed at enhancing hospital finances, patient safety, and physician satisfaction. The platform leverages artificial intelligence to extract relevant information from medical records, aid in diagnosing critical conditions, and produce accurate documentation. This enables physicians to save time, minimize liability, and maximize appropriate reimbursements.

Rivus Pharmaceuticals develops controlled metabolic accelerators aimed at enhancing cardio-metabolic health. The company focuses on improving cellular metabolism and addressing the root causes of common metabolic and cardiovascular diseases. They offer patients oral small-molecule therapeutics that target the fundamental metabolic risk factors contributing to cardiovascular mortality and morbidity.

Route 92 is the developer of an innovative medical device aimed at treating strokes and similar conditions. Their device features a percutaneous catheter for addressing acute ischemic stroke, a rapid aspiration thrombectomy system, and a delivery system for intra-cerebral implants. This technology empowers healthcare professionals to effectively treat patients and enhance the recovery process for those overcoming a stroke.

SalioGen Therapeutics has developed a genome engineering platform designed to deliver long-lasting, safe, and cost-effective non-viral gene therapies for individuals with genetic disorders. This mammal-based platform holds potential for curative non-viral gene therapy, allowing the healthcare sector to enhance processes in cell therapy, cell engineering, and biologics production for patients requiring treatment.

Santa Ana Bio, a biotechnology company, focuses on advancing precision immunology to treat autoimmune diseases. By utilizing single-cell genomics and sophisticated analytics, the company crafts personalized biologics tailored for autoimmune conditions. This approach allows patients to access targeted and effective treatments, resulting in expected outcomes and an enhanced quality of life.

Seismic Therapeutic is a biotechnology platform focused on speeding up the development of immunology drugs. By incorporating machine learning throughout the biologics discovery process, the company aims to tackle key obstacles in biologics discovery and drug development. This enables drug developers to explore innovative and faster methods for creating medicines for patients.

Sionna is a life sciences technology developer focused on creating highly effective and distinct treatments for cystic fibrosis. The company is advancing first-in-class small molecules targeting a unique pathway, aiming to fully normalize cystic fibrosis transmembrane conductance regulator (CFTR) function for the vast majority of those affected by the condition. Sionna's approach promises best-in-class efficacy, broad reach, and sustained benefits for cystic fibrosis patients.

SmarterDx has developed an automated pre-bill review platform to assist hospitals in maintaining revenue integrity. This platform automatically prioritizes diagnoses based on their financial significance to hospitals, accounting for factors like MS-DRG, 3M APR-DRG, Vizient, HCC, and Elixhauser models. By using this system, hospitals can ensure their revenue cycle teams thoroughly evaluate all relevant diagnoses, optimizing their financial outcomes.

SmithRx operates a pharmacy benefit management platform designed to emphasize transparency, efficiency, and data analytics. This platform provides employer customers and partners with maximum flexibility, control, and visibility over pharmacy benefits data. Through SmithRx's clinical programs, alternative sourcing, and transparent pricing, members can easily manage their prescription benefits and lower overall drug costs.

Strand Therapeutics delivers biotechnology services aimed at developing gene therapies through synthetic biology. The company's services focus on crafting immunotherapies that produce specific cancer-targeting proteins during treatment, allowing patients to enhance their immune response to combat cancer effectively.

Suki has developed a medical voice assistant designed to simplify clinical documentation and alleviate the administrative workload for healthcare professionals. This innovative platform leverages artificial intelligence and natural language processing to generate comprehensive clinical notes during or after patient consultations. By doing so, it enables doctors and surgeons to make better use of their time, mitigate burnout, and enhance both the quality of patient care and the precision of their medical records.

Syllable has developed a text and voice-based platform designed to enhance communication between patients and healthcare providers. This platform allows for seamless exchanges regarding primary care, specialist referrals, vaccinations, and general practice details, empowering patients to access healthcare information and guidance without needing to be in a clinical environment.

Synchron has developed an implantable stentrode aimed at establishing a brain-computer interface. This innovative company provides a minimally invasive device equipped with electrode arrays that decode brain signals to influence neural activity in targeted areas. This technology empowers patients with motor impairments to regain some control over digital devices, prosthetics, or other assistive technologies using just their thoughts.

Synthekine develops engineered cytokine therapeutics aimed at creating disease-specific treatments. By utilizing immunological insights, the company focuses on targeted protein engineering to produce transformative medicines. This approach empowers the medical community to enhance the treatment of cancer and autoimmune disorders.

Third Arc Bio is a biotech company focused on the research and development of multifunctional antibodies. Their platform aims to deliver groundbreaking therapies for solid tumors, inflammation, and immunological disorders by producing antibodies that form immune synapses for precise activation or inhibition of T cells. This enables medical companies to access advanced antibodies for treating immune system-related diseases.

Tome Biosciences is a biotechnology company that specializes in programmable gene insertion technology. They facilitate the insertion of genetic sequences of any size into any location within a genome, aiming to identify and eliminate DNA from similar bacteriophages during future infections. This innovative approach enables patient cures through advanced cell and genome engineering techniques.

Tomorrow Health offers data-driven medical equipment sourcing services designed to simplify the ordering and access of home medical equipment for patients and their families. The company connects patients with suppliers based on factors such as insurance coverage, service quality, location, and product expertise. It streamlines the ordering process, manages insurance and logistics, and offers personalized support. Additionally, Tomorrow Health collaborates with health plans and hospital systems to help patients adhere to their care plans by removing burdensome paperwork and minimizing delivery delays.

Triveni Bio has developed a drug discovery platform focused on creating targeted therapies for immune and inflammatory (I&I) disorders. Utilizing a genetics-informed methodology, the company identifies patients who are most likely to benefit from their treatments, enhancing precision and minimizing trial and error. This approach helps in advancing the development of novel therapies that are more effective and less toxic than existing options, ultimately providing patients with improved treatment outcomes.

Two Chairs operates as a mental health platform with the mission of making exceptional mental health care universally accessible. The platform uses an innovative strategy by carefully matching patients with ideal therapists through a research-backed process. Additionally, it employs a leading measurement-based care system to accelerate patient improvement, making it easier for patients to find the right therapists.

Unlearn develops machine-learning models that generate digital twins to populate intelligent control arms in clinical trials. By using AI to create synthetic patient data, the company's technology speeds up clinical studies by supplementing control groups. This approach reduces the time needed to develop new medications, allowing healthcare companies to deliver life-saving therapies to patients more swiftly.

Vanqua Bio is a biopharmaceutical company dedicated to creating innovative treatments for neurodegenerative diseases. The company specializes in discovering small-molecule activators of glucocerebrosidase and developing advanced programs aimed at the innate immune system, which can hasten the progression of various neurological conditions. This enables healthcare providers to improve patient outcomes with cutting-edge treatments for a range of disorders.

Verse Medical develops healthcare software designed to deliver dependable, timely, and cost-effective care for patients within their homes. Their platform provides a strong framework to facilitate the shift from hospitals to homes or from outpatient centers to home environments, allowing patients to experience seamless in-home care. It also aids healthcare administrators and clinicians in saving time.

Viome Life Sciences is a biotechnology and healthcare company focused on preventing and reversing chronic diseases. They digitize the human body and its microbiomes at a molecular level using at-home clinical-grade tests. These tests are analyzed through proprietary RNA sequencing technology, allowing them to decode precise health insights and biomarkers for various chronic diseases with the help of artificial intelligence and systems biology expertise. This enables healthcare providers to offer personalized nutrition recommendations and precision supplements to their patients.

Vizgen has developed a biomolecule profiling technology aimed at providing new insights into biological systems and diseases. The company's innovation centers on harnessing spatially resolved, single-cell gene expression profiling within intact tissue slices by utilizing spatial gene profiling measurements. This allows medical researchers to effectively explore biology at a systems level.